Brain cell transplant trial offers hope for rare Parkinson's-Like disease

This early-stage trial tests a single injection of dopamine-producing cells directly into the brain for people with multiple system atrophy (MSA), a rare and severe movement disorder. The main goal is to check safety and side effects in 9 participants aged 30 to 70. Researchers will also measure if symptoms improve over a year, but this is not a cure and ongoing medication may still be needed.